Policy Brief

Doxycycline Post-exposure Prophylaxis better known as Doxy-PEP is a recently introduced sexually transmitted infection (STI) prevention option. Extending access to Doxy-PEP to more individuals within communities for whom it is recommended merits consideration.

Key updates to PrEP access include recent changes to state and federal law and policy. This summary includes changes likely to affect PrEP access in California.

The brief provides an update of the local mpox situation and vaccinations as of November 2024.

A new CHPRC analysis evaluates the quality of the HIV-related information provided by ChatGPT and other popular chatbots powered by artificial intelligence (AI) and the extent to which these chatbots tailor their responses to address diverse HIV prevention needs.

Policy brief based on a study of seven California emergency departments (ED) implementing HIV Prevention Services (HPS) linkage programs. Three models for integrating HPS into the ED were identified and may serve as a guide for future protocol development.

Policy Brief An Analysis of the Scientific Evaluation of Orange County’s Discontinued Sterile Syringe Distribution Program and Its Implications for Drug Policy in California August 17, 2023 This brief analyzes the impact of Orange County’s sterile syringe distribution program on client and community outcomes, and also assesses how its impact influenced risk of HIV and […]

Policy Brief Are California pharmacists ready to provide long-acting injectable pre- exposure prophylaxis (PrEP) for HIV prevention? July 31, 2023 A new CHPRC analysis finds strong potential to increase access to long-acting injectable forms of HIV prevention in California pharmacies. Pharmacists surveyed were highly supportive of pharmacy-based PrEP provision under Senate Bill 159, and more […]

Policy Brief Senate Bill 159 Implementation California Pharmacists’ Perspectives on Opportunities and Challenges March 7, 2023 A new study from the California HIV/AIDS Policy Research Centers, in collaboration with the Center on Reproductive Health, Law, and Policy, Birth Control Pharmacist, and the California Society of Health-System Pharmacists, finds that more than 90% of California pharmacists […]

Policy Brief HIV and the Role of Federal Funds for Sexual and Reproductive Healthcare Serving Women in California February 16, 2023 Sexual and reproductive healthcare and rights (SRHR) are integral to gender equity, HIV prevention, and the provision of high-quality services for people of all genders living with HIV (PLWH).1 Sexual and reproductive healthcare (SRH) […]

Policy Brief The Use of HIV Over-the Counter (OTC) test in California from April to September 2013 January 3, 2023 Approval in mid-2012 of a consumer-controlled OTC HIV test by the Food and Drug Administration (FDA), which is responsible for drug and medical device approval for sales to the public, has made real the possibility […]